Literature DB >> 29207059

Therapeutic effect of adipose‑derived stem cell transplantation on optic nerve injury in rats.

Xu Li1, Shanyao Zhao2, Liangjun Wang3.   

Abstract

Adipose-derived stem cells (ADSCs) are mesenchymal stem cells in adipose tissue. ADSCs may differentiate into cells and tissues of different embryonic germ layers under specific inducing conditions. Previous studies have demonstrated that Schwann cells transformed from ADSCs can express nerve growth factors, generate nerve fibers and promote axonal regeneration in models of peripheral nerve injury. Stem cell transplantation is one of the potential techniques for the treatment of retinal ganglion cell injury. The present study developed an optic nerve crush injury rat model to investigate the therapeutic effect of fat stem cell transplantation on optic nerve injured rats. Retinal morphological changes were observed on day 3, 7, 14, 21 and 28 following optic nerve injury. It was determined that the number of retinal ganglion cells (RGCs) decreased with time following optic nerve injury; however, the number of RGCs in the stem cell transplantation group was higher compared with the buffer control group. The results of reverse transcription-quantitative polymerase chain reaction also demonstrated that the growth associated protein 43 mRNA expression level of the stem cell transplantation group was higher compared with the buffer control group. Apoptosis tests demonstrated that the stem cell transplantation group was able to resist the apoptosis of retinal cells. The present study demonstrated that in vivo transplantation of ADSCs can improve the survival rate of RGCs in rats with optic nerve injury and to resist the apoptosis of retinal cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29207059     DOI: 10.3892/mmr.2017.8103

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: a phase 1/2 study.

Authors:  Ayse Oner; Zeynep Burcin Gonen; Duygu Gülmez Sevim; Neslihan Sinim Kahraman; Metin Unlu
Journal:  Int Ophthalmol       Date:  2019-07-15       Impact factor: 2.031

Review 2.  Traumatic optic neuropathy: a review of current studies.

Authors:  Bin Chen; Hengsen Zhang; Qing Zhai; Huaipeng Li; Chunxia Wang; Yong Wang
Journal:  Neurosurg Rev       Date:  2022-01-16       Impact factor: 3.042

3.  [Protective effect of Epothilone D against traumatic optic nerve injury in rats].

Authors:  P Wang; S Luo; C Shen; Z Yu; Z Nie; Z Li; J Wen; M Li; X Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-04-20

Review 4.  Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis.

Authors:  Licheng Li; Yang Yu; Shu Lin; Jianmin Hu
Journal:  Stem Cell Res Ther       Date:  2022-06-07       Impact factor: 8.079

5.  Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy.

Authors:  Paolo Giuseppe Limoli; Celeste Limoli; Enzo Maria Vingolo; Federica Franzone; Marcella Nebbioso
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

6.  Extracellular vesicles derived from human ES-MSCs protect retinal ganglion cells and preserve retinal function in a rodent model of optic nerve injury.

Authors:  Seyedeh-Zahra Seyedrazizadeh; Sara Poosti; Abdoreza Nazari; Mehdi Alikhani; Faezeh Shekari; Farzad Pakdel; Koorosh Shahpasand; Leila Satarian; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2020-05-27       Impact factor: 6.832

7.  Stem cell therapy for retinal ganglion cell degeneration.

Authors:  Ling-Ping Cen; Tsz Kin Ng
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.